Company Monitoring Page for Sanofi

latest headlines for company on cafepharma

Bernie Sanders weighs Senate hearing for largest insulin makers
Seeking Alpha
Thu, 04/13/23 - 11:53 am
Tags:
Bernie Sanders, diabetes, insulin, drug pricing, Eli Lilly, Sanofi, Novo Nordisk, Senate
Sanofi, AstraZeneca and Sobi simplify Beyfortus agreements ahead of US launch
Biopharma Reporter
Wed, 04/12/23 - 11:30 am
Tags:
Sanofi, AstraZeneca, Sobi, Beyfortus, RSV
Pfizer's fortunes overshadow first-quarter dealmaking
EP Vantage
Wed, 04/12/23 - 10:22 am
Tags:
M&A, Pfizer, Seagen, Sanofi, Provention Bio, AstraZeneca, CinCor, Chiesi, Amryt, Ipsen, Albireo
Sanofi's Provention buyout hit with FTC delay. Will Pfizer's Seagen deal go off as planned?
Fierce Pharma
Tue, 04/11/23 - 11:46 am
Tags:
M&A, antitrust, FTC, Sanofi, Provention Bio, Pfizer, Seagen
Biopharma stocks go back to bleak
EP Vantage
Thu, 04/6/23 - 09:51 am
Tags:
Albireo Pharma, Amryt Pharma, Apellis Pharmaceuticals, AstraZeneca, BridgeBio, Novo Nordisk, Pfizer, Protagonist Therapeutics, Provention Bio, Reata Pharmaceuticals, Regeneron, Sanofi, Seagen
Expanding its pandemic influenza preparedness, Sanofi breaks ground on state-of-the-art facility in Pennsylvania
ROI-NJ
Wed, 04/5/23 - 07:17 pm
Tags:
Sanofi, BARDA, drug manufacturing, vaccines, Pennsylvania
Sanofi attempting to spin off consumer health unit in India: report
Fierce Pharma
Fri, 03/31/23 - 11:52 am
Tags:
Sanofi, consumer health, India, spinoffs
Galapagos, following Sanofi’s playbook, offloads French R&D site to drug discovery CRO
Fierce Biotech
Fri, 03/31/23 - 10:27 am
Tags:
Galapagos, Sanofi, R&D, CROs, NovAliX
Top 10 pharma R&D budgets in 2022
Fierce Biotech
Mon, 03/27/23 - 10:21 pm
Tags:
R&D, Roche, JNJ, Merck, Pfizer, Novartis, AstraZeneca, Bristol Myers Squibb, Eli Lilly, Sanofi, AbbVie
Sanofi, Regeneron's Dupixent could hit $20B in peak sales with COPD expansion: analyst
Fierce Pharma
Sun, 03/26/23 - 11:30 pm
Tags:
Sanofi, Regeneron, Dupixent, COPD
Sanofi and Regeneron's Dupixent scores trial win in tough-to-treat COPD
Fierce Pharma
Thu, 03/23/23 - 11:44 am
Tags:
Sanofi, Regeneron, Dupixent, COPD, clinical trials
AAD: Will Sanofi and Regeneron’s Dupixent be a game-changer or just another antibody on the COPD scrapheap?
Fierce Pharma
Mon, 03/20/23 - 10:06 am
Tags:
Sanofi, Regeneron, Dupixent, COPD
Three's company: Sanofi follows lead of Lilly and Novo, slashes insulin price by 78% and caps out-of-pocket costs
Endpoints
Thu, 03/16/23 - 09:16 pm
Tags:
Sanofi, Lantus, insulin, diabetes, drug pricing, Eli Lilly, Novo Nordisk
Sanofi throws down $2.9B to acquire diabetes partner Provention Bio
Fierce Pharma
Mon, 03/13/23 - 10:08 am
Tags:
Sanofi, Provention Bio, M&A, diabetes
Sanders urges Sanofi, Novo Nordisk to be like Eli Lilly in reducing insulin prices
Fierce Pharma
Sun, 03/5/23 - 03:26 pm
Tags:
Eli Lilly, Novo Nordisk, Sanofi, insulin, Bernie Sanders, drug pricing
Sanofi’s clinical trial of hemophilia A therapy in children meets endpoint
Clinical Trials Arena
Sun, 03/5/23 - 03:12 pm
Tags:
Sanofi, clinical trials, hemophilia A, Altuviiio
FDA Approves Regeneron-Sanofi's Sarilumab As First Biologic For Stiffness, Pain In Muscles
Yahoo/Benzinga
Wed, 03/1/23 - 07:07 pm
Tags:
Regeneron, Sanofi, FDA, Kevzara, Sarilumab, polymyalgia rheumatica
Junshi's lipid lowering drug hits phase 3 goals, teeing up challenge to Amgen, Sanofi in growth market
Fierce Biotech
Tue, 02/28/23 - 10:03 am
Tags:
Junshi Biosciences, Amgen, Sanofi, China, clinical trials, PCSK9 inhibitors
FDA approves Sanofi’s long-lasting hemophilia drug
BioPharma Dive
Thu, 02/23/23 - 04:32 pm
Tags:
Sanofi, FDA, hemophilia A, Altuviiio
Pfizer's maternal RSV vaccine filing gets priority review, setting up showdown with AstraZeneca, Sanofi
Fierce Pharma
Tue, 02/21/23 - 10:26 am
Tags:
Pfizer, RSV, vaccines, GSK, AstraZeneca, Sanofi, RSVpreF

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.